Crosstalk between 1,25(OH) 2 -Vitamin D 3 and the growth factors EGF and PDGF-BB: Impact on CYP24A1 expression and cell proliferation.
Autor: | Olsson F; Department of Pharmaceutical Biosciences, Uppsala University, Biomedical Center, Box 591, SE-75124, Uppsala, Sweden., Wåhlén E; Department of Pharmaceutical Biosciences, Uppsala University, Biomedical Center, Box 591, SE-75124, Uppsala, Sweden., Heldin J; Department of Pharmaceutical Biosciences, Uppsala University, Biomedical Center, Box 591, SE-75124, Uppsala, Sweden., Söderberg O; Department of Pharmaceutical Biosciences, Uppsala University, Biomedical Center, Box 591, SE-75124, Uppsala, Sweden., Norlin M; Department of Pharmaceutical Biosciences, Uppsala University, Biomedical Center, Box 591, SE-75124, Uppsala, Sweden., Lennartsson J; Department of Pharmaceutical Biosciences, Uppsala University, Biomedical Center, Box 591, SE-75124, Uppsala, Sweden. Electronic address: johan.lennartsson@uu.se. |
---|---|
Jazyk: | angličtina |
Zdroj: | Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Dec 03; Vol. 736, pp. 150866. Date of Electronic Publication: 2024 Oct 21. |
DOI: | 10.1016/j.bbrc.2024.150866 |
Abstrakt: | This study explored the signaling interplay between the vitamin D receptor (VDR) and receptor tyrosine kinases (RTKs). Epidermal growth factor (EGF) and platelet-derived growth factor (PDGF)-BB promotes cell proliferation in normal and cancer cells. At the same time, the active form of vitamin D (1,25(OH) Competing Interests: Declaration of competing interest The authors have nothing to declare. (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |